Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-26 | 2020-03-27 | 107199 |
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-02-26 | 2020-04-07 | 107196 |
APO-QUINAPRIL | 10MG | TABLET | Resolved | 2020-02-13 | 2020-06-22 | 106056 |
APO-OLANZAPINE | 5.0MG | TABLET | Resolved | 2020-02-13 | 2020-06-02 | 106006 |
APO-NAPROXEN | 250MG | TABLET | Resolved | 2020-02-13 | 2020-02-28 | 106003 |
APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2020-02-13 | 2020-10-13 | 106000 |
APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2020-02-13 | 2020-04-14 | 105997 |
APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-02-13 | 2020-06-08 | 105994 |
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-02-13 | 2020-04-07 | 105991 |
APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2020-02-13 | 2020-04-23 | 105988 |
APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2020-02-05 | 2020-03-27 | 105367 |
APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | SOLUTION | Resolved | 2020-02-05 | 2020-03-06 | 105364 |
APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2020-02-05 | 2020-03-11 | 105359 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2020-02-05 | 2020-06-02 | 105356 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-02-05 | 2020-02-21 | 105352 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-02-05 | 2020-02-18 | 105348 |
APO-LAMOTRIGINE | 100MG | TABLET | Resolved | 2020-02-05 | 2020-03-27 | 105345 |
APO-FLUOXETINE | 20MG | SOLUTION | Resolved | 2020-02-05 | 2020-09-04 | 105340 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2020-02-05 | 2020-02-25 | 105333 |
APO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-02-05 | 2020-03-03 | 105330 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |